Literature DB >> 3664989

Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow.

B Massie1, M Conway, R Yonge, S Frostick, J Ledingham, P Sleight, G Radda, B Rajagopalan.   

Abstract

We and others have previously demonstrated excessive phosphocreatine (PCr) depletion and acidosis in skeletal muscle during exercise in patients with congestive heart failure (CHF). In the present study, we performed serial measurements of PCr and pH during gradually incremental flexor digitorum superficialis exercise in 22 patients with CHF and 11 age-matched controls to determine: (1) whether abnormalities were present at the same relative workloads (a comparison that would at least partially compensate for differences in muscle mass), (2) the temporable course of the metabolic changes, (3) the relationship of the metabolic findings to clinical variables, and (4) the relationship of the metabolic abnormalities to forearm blood flow. The patients with CHF had significantly lower [PCr] and pH at all submaximal levels of exercise, and these abnormalities were apparent from the onset of low-level exercise. There was considerable heterogeneity among the patients with CHF with respect to the metabolic findings, with 14 of 22 exhibiting either PCr or pH values more than 2 SDs below normal. Patients whose capacity was more limited during the protocol had lower [PCr], and especially pH, at low loads than did other patients with CHF or the control subjects. The more symptomatic patients and those with more limited bicycle exercise tolerance also had lower pH values. In contrast, there were no significant differences in forearm blood flow between the patients and controls and no relationship between forearm blood and either clinical variables or the metabolic findings. These results indicate that skeletal muscle metabolic abnormalities are present in many patients with CHF and that they are not primarily due to either muscle atrophy or impaired blood flow. These changes may explain in part the marked heterogeneity of symptom status and exercise capacity of patients with similar degrees of cardiac dysfunction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3664989     DOI: 10.1161/01.cir.76.5.1009

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  56 in total

1.  Dissociation between muscle metabolism and oxygen kinetics during recovery from exercise in patients with chronic heart failure.

Authors:  A Hanada; K Okita; K Yonezawa; M Ohtsubo; T Kohya; T Murakami; H Nishijima; M Tamura; A Kitabatake
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

Review 2.  Peripheral limitations of maximal aerobic capacity in patients with chronic heart failure.

Authors:  Stuart D Katz; Haoyi Zheng
Journal:  J Nucl Cardiol       Date:  2002 Mar-Apr       Impact factor: 5.952

Review 3.  Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure.

Authors:  Holly R Middlekauff
Journal:  Circ Heart Fail       Date:  2010-07       Impact factor: 8.790

4.  After-effects of exercise on haemodynamics and muscle sympathetic nerve activity in young patients with dilated cardiomyopathy.

Authors:  K Hara; J S Floras
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

5.  MicroRNA-432 targeting E2F3 and P55PIK inhibits myogenesis through PI3K/AKT/mTOR signaling pathway.

Authors:  Meilin Ma; Xiangming Wang; Xiaochang Chen; Rui Cai; Fenfen Chen; Wuzi Dong; Gongshe Yang; Weijun Pang
Journal:  RNA Biol       Date:  2017-01-13       Impact factor: 4.652

Review 6.  Origin of symptoms in chronic heart failure.

Authors:  A L Clark
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

Review 7.  Exercise training as therapy for chronic heart failure.

Authors:  N G Uren; D P Lipkin
Journal:  Br Heart J       Date:  1992-06

Review 8.  Nuclear magnetic resonance in clinical pharmacology and measurement of therapeutic response.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

9.  Cardiac metabolism during exercise in healthy volunteers measured by 31P magnetic resonance spectroscopy.

Authors:  M A Conway; J D Bristow; M J Blackledge; B Rajagopalan; G K Radda
Journal:  Br Heart J       Date:  1991-01

Review 10.  Metabolic and structural impairment of skeletal muscle in heart failure.

Authors:  Cynthia Zizola; P Christian Schulze
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.